These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 813923)
1. Quantitative studies of the growth and rejection of allogeneic tumour cells in mouse cerebrospinal fluid. Elimination in the absence of H-2 differences. Doherty PC; Zinkernagel RM Clin Exp Immunol; 1975 Feb; 19(2):355-66. PubMed ID: 813923 [TBL] [Abstract][Full Text] [Related]
2. Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex. Doherty PC; Zinernagel RM J Immunol; 1975 Jan; 114(1 Pt 1):30-3. PubMed ID: 1078677 [TBL] [Abstract][Full Text] [Related]
3. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens. Kedar E; Bonavida B J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889 [TBL] [Abstract][Full Text] [Related]
4. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages. Jones B; Jones TC Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994 [TBL] [Abstract][Full Text] [Related]
5. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level. Sensi M; Orosz CG; Bach FH J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. Streilein JW; Niederkorn JY J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766 [TBL] [Abstract][Full Text] [Related]
7. Recovery of activated cytotoxic T cells from minor H incompatible tumor graft rejection sites. Ksander BR; Streilein JW J Immunol; 1989 Jul; 143(2):426-31. PubMed ID: 2500481 [TBL] [Abstract][Full Text] [Related]
8. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice. Germain RN; Williams RM; Benacerraf B Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167 [TBL] [Abstract][Full Text] [Related]
9. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2. Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360 [TBL] [Abstract][Full Text] [Related]
10. Specific immune lysis of paramyxovirus-infected cells by H-2-compatible thymus-derived lymphocytes. Doherty PC; Zinkernagel RM Immunology; 1976 Jul; 31(1):27-32. PubMed ID: 194830 [TBL] [Abstract][Full Text] [Related]
11. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice. Takei F; Levy JG; Kilburn DG J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160 [TBL] [Abstract][Full Text] [Related]
12. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro. Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374 [TBL] [Abstract][Full Text] [Related]
13. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response. Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798 [TBL] [Abstract][Full Text] [Related]
14. Specific reversal of cytolytic T cell-target cell functional binding is induced by free target cells. Balk SP; Mescher MF J Immunol; 1981 Jul; 127(1):51-7. PubMed ID: 6787131 [TBL] [Abstract][Full Text] [Related]
15. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes. Tremblay N; Fontaine P; Perreault C Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709 [TBL] [Abstract][Full Text] [Related]
16. Failure of anti-T cell monoclonal antibodies to prevent acute tumor allograft rejection is associated with their inability to deplete or inactivate T cells at the site of rejection. Rakhmilevich AL Transplantation; 1994 Jul; 58(1):72-80. PubMed ID: 7913562 [TBL] [Abstract][Full Text] [Related]
17. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect. Igarashi T; Okada M; Kishimoto S; Yamamura Y Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916 [TBL] [Abstract][Full Text] [Related]
18. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Niederkorn J; Streilein JW; Shadduck JA Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):355-63. PubMed ID: 6782034 [TBL] [Abstract][Full Text] [Related]
19. Analysis of cytotoxic T cell responses to intracameral allogeneic tumors. Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 1989 Feb; 30(2):323-9. PubMed ID: 2492486 [TBL] [Abstract][Full Text] [Related]
20. The genetic control of T cell-mediated immunity against the DBA/2 mastocytoma P-815. II. Low responsiveness in T cell-mediated cytotoxicity accompanied by the inability to produce antibodies in a secondary response. Kölsch E Eur J Immunol; 1975 Aug; 5(8):527-32. PubMed ID: 824139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]